{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:42:50Z","timestamp":1791225770968,"version":"4.1.0"},"reference-count":169,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.bbrc.2020.01.123","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T03:31:32Z","timestamp":1581046292000},"page":"772-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Natural and synthetic drugs used for the treatment of the dementia"],"prefix":"10.1016","volume":"524","author":[{"given":"Valery M.","family":"Dembitsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilya","family":"Dzhemileva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Gloriozova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"D\u2019yakonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.01.123_bib1","first-page":"713","article-title":"Dementia in women","volume":"103","author":"Derreberry","year":"2019","journal-title":"Med. Clin."},{"key":"10.1016\/j.bbrc.2020.01.123_bib2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/gps.5140","article-title":"Hospital readmission in persons with dementia: a systematic review","volume":"34","author":"Ma","year":"2019","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.bbrc.2020.01.123_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1980-57642018dn13-010001","article-title":"Cognitive reserve and dementia A scientometric review","volume":"13","author":"Pestana","year":"2019","journal-title":"Dement Neuropsy"},{"key":"10.1016\/j.bbrc.2020.01.123_bib4","first-page":"134","article-title":"Epidemiology of vascular dementia","volume":"28","author":"Leys","year":"1998","journal-title":"Haemostasis"},{"key":"10.1016\/j.bbrc.2020.01.123_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1192\/bjp.180.2.161","article-title":"Rating scales in old age psychiatry","volume":"180","author":"Burns","year":"2002","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbrc.2020.01.123_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.coph.2019.01.004","article-title":"The de-Alzheimerization of age-related dementias: implications for drug targets and approaches to effective therapeutics","volume":"18","author":"Mullane","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib7","series-title":"World Alzheimer Report: the Global Impact of Dementia: an Analysis of Prevalence, Incidence, Cost and Trends 2015","author":"Prince","year":"2015"},{"key":"10.1016\/j.bbrc.2020.01.123_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1212\/WNL.0000000000005941","article-title":"World dementia: one approach does not fit all","volume":"91","author":"Alladi","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2020.01.123_bib9","doi-asserted-by":"crossref","first-page":"E2161","DOI":"10.3390\/ijms20092161","article-title":"Targeting apolipoprotein E for Alzheimer\u2019s disease: an industry perspective","volume":"20","author":"Suidan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2020.01.123_bib10","article-title":"Neuropsychological assessment in preclinical and prodromal Alzheimer disease: a global perspective","volume":"9","author":"Watermeyer","year":"2019","journal-title":"J.\u00a0Glob. Health."},{"key":"10.1016\/j.bbrc.2020.01.123_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-510X(98)00128-2","article-title":"History of dementia and dementia in history: an overview","volume":"158","author":"Boller","year":"1998","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.bbrc.2020.01.123_bib12","article-title":"The natural history of Parkinson\u2019s disease","volume":"253","author":"Poewe","year":"2006","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0749-0690(18)30771-7","article-title":"What is a complete work-up for dementia?","volume":"4","author":"Horowitz","year":"1988","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.bbrc.2020.01.123_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00002093-199100520-00008","article-title":"Diagnosis of multi-infarct dementia","volume":"5","author":"Erkinjuntii","year":"1991","journal-title":"Alzheimer Dis. Assoc. Disord. Summer"},{"key":"10.1016\/j.bbrc.2020.01.123_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4613-0665-8_5","article-title":"The diagnosis of Alzheimer\u2019s disease","volume":"282","author":"Murden","year":"1990","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib16","article-title":"A\u00a0brief history of Alzheimer\u2019s disease: multiple meanings separated by a common name","volume":"26","author":"Knopman","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2020.01.123_bib17","first-page":"1198","article-title":"Dementia","volume":"14","author":"Warner","year":"2005","journal-title":"Clin. Evid."},{"key":"10.1016\/j.bbrc.2020.01.123_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00093-4","article-title":"Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer\u2019s disease?","volume":"346","author":"Benzi","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2125.1999.00026.x","article-title":"Acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"48","author":"McGleenon","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib20","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0047-6374(01)00309-8","article-title":"Acetylcholinesterase in Alzheimer\u2019s disease","volume":"122","author":"Talesa","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbrc.2020.01.123_bib21","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1021\/acschemneuro.7b00270","article-title":"Classics in chemical neuroscience: Memantine","volume":"8","author":"Alam","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbrc.2020.01.123_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1515\/jbcpp-2016-0147","article-title":"Natural product for the treatment of Alzheimer\u2019s disease","volume":"28","author":"Bui","year":"2017","journal-title":"J.\u00a0Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib23","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.2174\/0929867324666170712161829","article-title":"An overview of new possible treatments of Alzheimer\u2019s disease, based on natural products and semi-synthetic compounds","volume":"24","author":"Zanforlin","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biotechadv.2016.12.005","article-title":"Natural products against Alzheimer\u2019s disease: pharmaco-therapeutics and biotechnological interventions","volume":"35","author":"Dey","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bbrc.2020.01.123_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12272-014-0503-5","article-title":"Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer\u2019s disease, Parkinson\u2019s disease and ischemic brain stroke: their molecular targets and action mechanisms","volume":"38","author":"Choi","year":"2015","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.bbrc.2020.01.123_bib26","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2174\/15680266113139990142","article-title":"Natural products as sources of new lead compounds for the treatment of Alzheimer\u2019s disease","volume":"13","author":"Huang","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejmech.2007.04.019","article-title":"Bioactive peroxides as potential therapeutic agents","volume":"43","author":"Dembitsky","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/2471-8521.100005","article-title":"Bioactive fungal endoperoxides","volume":"1","author":"Dembitsky","year":"2015","journal-title":"Med. Mycol. Open Access"},{"key":"10.1016\/j.bbrc.2020.01.123_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/138955707780859396","article-title":"Natural peroxy anticancer agents","volume":"7","author":"Dembitsky","year":"2007","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib30","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1007\/s00253-018-8968-7","article-title":"Naturally occurring aromatic steroids and their biological activities","volume":"102","author":"Dembitsky","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib31","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1007\/s00253-018-9211-2","article-title":"Peroxy steroids derived from plant and fungi and their biological activities","volume":"102","author":"Vil","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/vjch.201960001","article-title":"Highly oxygenated isoprenoid lipids derived from terrestrial and aquatic sources: origin, structures and biological activities","volume":"57","author":"Vil","year":"2019","journal-title":"Vietnam J. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/00002512-200320060-00005","volume":"20","author":"Jarvis","year":"2003","journal-title":"Memantine, Drugs Aging"},{"key":"10.1016\/j.bbrc.2020.01.123_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6468(08)70315-1","article-title":"Aminoadamantane derivatives","volume":"18","author":"Tilley","year":"1981","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib35","first-page":"91","article-title":"Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties","volume":"43","author":"Kornhuber","year":"1994","journal-title":"J.\u00a0Neural. Transm. Suppl."},{"key":"10.1016\/j.bbrc.2020.01.123_bib36","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1517\/13543784.9.6.1397","article-title":"Evaluation of memantine for neuroprotection in dementia","volume":"9","author":"Jain","year":"2000","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.bbrc.2020.01.123_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/00019053-200523020-00010","article-title":"Memantine: a pharmacoeconomic review of its use in moderate-to-severe Alzheimer\u2019s disease","volume":"23","author":"Plosker","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.bbrc.2020.01.123_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14740330802528420","article-title":"Memantine: a comprehensive review of safety and efficacy","volume":"8","author":"Kavirajan","year":"2009","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.bbrc.2020.01.123_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2018.03.023","article-title":"The role of memantine in the treatment of major depressive disorder: clinical efficacy and mechanisms of action","volume":"827","author":"Amidfar","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib41","first-page":"169","article-title":"Improved syntheses of aminoacridines part I. The five isomeric monoamino-acridines","volume":"64","author":"Albert","year":"1945","journal-title":"J.\u00a0Soc. Chem. Ind."},{"key":"10.1016\/j.bbrc.2020.01.123_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000116478","article-title":"Tacrine in the treatment of Alzheimer\u2019s disease. A clinical update and recent pharmacologic studies","volume":"29","author":"Summers","year":"1989","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib43","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2165\/00002512-199404060-00006","article-title":"Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer\u2019s disease","volume":"4","author":"Wagstaff","year":"1994","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bbrc.2020.01.123_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(95)90526-X","volume":"345","author":"Davis","year":"1995","journal-title":"Tacrine. Lancet"},{"key":"10.1016\/j.bbrc.2020.01.123_bib45","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.2174\/0929867324666170309123920","article-title":"Tacrine-based multifunctional agents in Alzheimer\u2019s disease: an old story in continuous development","volume":"24","author":"Milelli","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/tcr.201800155","article-title":"Tacrines as therapeutic agents for Alzheimer\u2019s disease. IV. The tacripyrines and related annulated racrines","volume":"19","author":"Bartolini","year":"2019","journal-title":"Chem. Rec."},{"key":"10.1016\/j.bbrc.2020.01.123_bib47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2165\/00023210-199401030-00008","article-title":"Velnacrine in Alzheimer\u2019s disease","volume":"1","author":"Goa","year":"1994","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbrc.2020.01.123_bib48","first-page":"CD004748","article-title":"Velnacrine for Alzheimer\u2019s disease","volume":"2","author":"Birks","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2020.01.123_bib49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2165\/00003088-199529020-00005","article-title":"Clinical pharmacokinetics of drugs for Alzheimer\u2019s disease","volume":"29","author":"Parnetti","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bbrc.2020.01.123_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jep.2017.12.015","article-title":"Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer\u2019s disease","volume":"215","author":"Sahoo","year":"2018","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00002512-199813050-00005","article-title":"Rivastigmine: a review of its use in Alzheimer\u2019s disease","volume":"13","author":"Spencer","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bbrc.2020.01.123_bib52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2017.09.043","article-title":"The present and future of pharmacotherapy of Alzheimer\u2019s disease: a comprehensive review","volume":"815","author":"Anand","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/CIA.S129145","article-title":"Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson\u2019s disease dementia","volume":"12","author":"Kandiah","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bbrc.2020.01.123_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1592\/phco.20.1.1.34664","article-title":"Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer\u2019s disease","volume":"20","author":"Jann","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbrc.2020.01.123_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/ciia.2007.2.1.17","article-title":"Rivastigmine in the treatment of Alzheimer\u2019s disease: an update","volume":"2","author":"Onor","year":"2007","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bbrc.2020.01.123_bib56","first-page":"458","article-title":"Cognitive impairment in Parkinson\u2019s disease","volume":"27","author":"Ransmayr","year":"2015","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.bbrc.2020.01.123_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2165\/00002512-199710030-00007","volume":"10","author":"Bryson","year":"1997","journal-title":"Donepezil. Drugs & Aging"},{"key":"10.1016\/j.bbrc.2020.01.123_bib58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/14656566.2013.760543","article-title":"A\u00a010-year perspective on donepezil","volume":"14","author":"Cheewakriengkrai","year":"2013","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.bbrc.2020.01.123_bib59","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1080\/14656566.2018.1519022","article-title":"An evaluation of memantine ER\u00a0+ donepezil for the treatment of Alzheimer\u2019s disease","volume":"19","author":"Calhoun","year":"2018","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.bbrc.2020.01.123_bib60","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejmech.2018.09.031","article-title":"Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer\u2019s disease","volume":"158","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1389557513666131119201353","article-title":"Donepezil: an important prototype to the design of new drug candidates for Alzheimer\u2019s disease","volume":"14","author":"Rodrigues Sim\u00f5es","year":"2014","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib62","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3389\/fphar.2018.01192","article-title":"Naturally occurring acetylcholinesterase inhibitors and their potential use for Alzheimer\u2019s disease therapy","volume":"9","author":"dos Santos","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1533317517734352","article-title":"Acetylcholinesterase inhibitors: beneficial effects on comorbidities in patients with Alzheimer\u2019s disease","volume":"33","author":"Kaushik","year":"2018","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.bbrc.2020.01.123_bib64","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1515\/jbcpp-2016-0147","article-title":"Natural product for the treatment of Alzheimer\u2019s disease","volume":"28","author":"Bui","year":"2017","journal-title":"J.\u00a0Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib65","first-page":"837","article-title":"The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity","volume":"64","author":"Liu","year":"1986","journal-title":"J.\u00a0Can. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib66","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3109\/13880209.2010.485619","article-title":"Huperzine alkaloids from Australasian and southeast Asian Huperzia","volume":"48","author":"Lim","year":"2010","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jep.2007.05.030","article-title":"Huperzine A from Huperzia species - an ethnopharmacolgical review","volume":"113","author":"Ma","year":"2007","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib68","first-page":"155","article-title":"Huperzine A - an interesting anticholinesterase compound from the Chinese herbal medicine","volume":"41","author":"Patocka","year":"1998","journal-title":"Acta Med."},{"key":"10.1016\/j.bbrc.2020.01.123_bib69","article-title":"Huperzine A for Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized clinical trials","volume":"8","author":"Yang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2020.01.123_bib70","first-page":"CD010284","article-title":"Traditional Chinese herbal medicine for vascular dementia","volume":"12","author":"Chan","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2020.01.123_bib71","first-page":"CD007365","article-title":"Huperzine A for vascular dementia","volume":"2","author":"Hao","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2020.01.123_bib72","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cbi.2008.05.023","article-title":"[+]-Huperzine A treatment protects against N-methyl-D-aspartate-induced seizure\/status epilepticus in rats","volume":"175","author":"Coleman","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2020.01.123_bib73","first-page":"110","article-title":"Anti-cholinesterase activity of huperzine A","volume":"7","author":"Wang","year":"1986","journal-title":"Zhongguo Yaoli Xuebao"},{"key":"10.1016\/j.bbrc.2020.01.123_bib74","first-page":"1216","article-title":"Alkaloids of Galanthus woronowi. I. Isolation of galanthamine","volume":"17","author":"Proskurnina","year":"1947","journal-title":"J.\u00a0Gen. Chim. Gen. USSR"},{"key":"10.1016\/j.bbrc.2020.01.123_bib75","first-page":"1899","article-title":"Alkaloids of Galanthus woronowi. II. Isolation of new alkaloid","volume":"22","author":"Proskurnina","year":"1952","journal-title":"J.\u00a0Gen. Chem. USSR"},{"key":"10.1016\/j.bbrc.2020.01.123_bib76","first-page":"23","article-title":"Phytochemical investigation of Galanthus nivalis var. gracilis","volume":"7","author":"Bubeva-Ivanova","year":"1957","journal-title":"Fr. Polit."},{"key":"10.1016\/j.bbrc.2020.01.123_bib77","series-title":"Nivalin: Pharmacology and Clinical Application","author":"Paskov","year":"1959"},{"key":"10.1016\/j.bbrc.2020.01.123_bib78","first-page":"27","article-title":"On the pharmacology of the new alkaloid galantamine","volume":"14","author":"Mashkovsky","year":"1951","journal-title":"Farmakologia Toxicologia"},{"key":"10.1016\/j.bbrc.2020.01.123_bib79","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1017\/S0029665116002962","article-title":"Potential benefits of phytochemicals against Alzheimer\u2019s disease","volume":"76","author":"Wightman","year":"2017","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.bbrc.2020.01.123_bib80","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J.\u00a0Alzheim. Dis."},{"key":"10.1016\/j.bbrc.2020.01.123_bib81","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-122140","article-title":"A\u00a0meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer\u2019s disease","volume":"35","author":"Di Santo","year":"2013","journal-title":"J.\u00a0Alzheim. Dis."},{"key":"10.1016\/j.bbrc.2020.01.123_bib82","series-title":"A\u00a0Handbook of Materia Medica","first-page":"53","author":"Potter","year":"1893"},{"key":"10.1016\/j.bbrc.2020.01.123_bib83","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1113\/jphysiol.1910.sp001400","article-title":"The action of atropine, pilocarpine and physostigmine","volume":"41","author":"Cushny","year":"1910","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib84","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/ja01307a051","article-title":"Studies in the indole series. V. The complete synthesis of physostigmine (Eserine)","volume":"57","author":"Julian","year":"1935","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.bbrc.2020.01.123_bib85","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.82.2134.497.a","article-title":"A\u00a0contribution to the pharmacology of physostigmine","volume":"82","author":"Linegar","year":"1935","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.01.123_bib86","first-page":"1300","article-title":"Development of physostigmine from a poisonous plant to an antidote. One of the most important drugs in the development of modern medicine?","volume":"112","author":"Rygnestad","year":"1992","journal-title":"Tidsskr. Nor. Laegeforen."},{"key":"10.1016\/j.bbrc.2020.01.123_bib87","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s13181-019-00697-z","article-title":"Adverse effects of physostigmine","volume":"15","author":"Arens","year":"2019","journal-title":"J.\u00a0Med. Toxicol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib88","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MJT.0b013e3181f0cbb4","article-title":"Use of physostigmine for hallucinogenic plant poisoning in a teenager: case report and review of the literature","volume":"19","author":"Glatstein","year":"2012","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.bbrc.2020.01.123_bib89","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-2006-962460","article-title":"Alkaloids from Narcissus jacetanus","volume":"54","author":"Bastida","year":"1988","journal-title":"Planta Med."},{"key":"10.1016\/j.bbrc.2020.01.123_bib90","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/S0031-9422(00)84525-2","article-title":"Phenanthridine alkaloids from Narcissus assoanus","volume":"25","author":"Llabr\u00e9s","year":"1986","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbrc.2020.01.123_bib91","first-page":"367","article-title":"Study on the alkaloid, Allicin, glycoside and saponin composition of the leaves of Sansevieria liberica G\u00e9r\u00f4me and Labroy by gas chromatography","volume":"12","author":"Ikewuchi","year":"2011","journal-title":"Pacific J. Sci. Technol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib92","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/fsn3.449","article-title":"Bioactive phytochemicals in an aqueous extract of the leaves of Talinum triangulare","volume":"5","author":"Ikewuchi","year":"2017","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.bbrc.2020.01.123_bib93","first-page":"959","article-title":"Acetylcholinesterase Inhibition within the lycorine series of Amaryllidaceae alkaloids","volume":"7","author":"Nair","year":"2012","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.bbrc.2020.01.123_bib94","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.phymed.2007.02.002","article-title":"Acetylcholinesterase inhibitors from plants","volume":"14","author":"Mukherjeea","year":"2007","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2020.01.123_bib95","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1016\/j.bmc.2005.03.045","article-title":"Indole alkaloids from Tabernaemontana australis (M\u00fcell. Arg) Miers that inhibit acetylcholinesterase enzyme","volume":"13","author":"Andrade","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib96","first-page":"2673","article-title":"Hericerin, a new pollen growth inhibitor from the mushroom Hericium erinaceum","volume":"55","author":"Kimura","year":"1991","journal-title":"Agric. Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib97","first-page":"92","article-title":"Hericenones and erinacines: stimulators of nerve growth factor (NGF) biosynthesis in Hericium erinaceus","volume":"1","author":"Ma","year":"2010","journal-title":"Int. J. Fungal Biol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib98","first-page":"121","article-title":"Cholinesterase inhibitors from botanicals","volume":"7","author":"Ahmed","year":"2013","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.bbrc.2020.01.123_bib99","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/13880209.2012.738423","article-title":"Plants traditionally used in age-related brain disorders (dementia): an ethanopharmacological survey","volume":"51","author":"Natarajan","year":"2013","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib100","first-page":"126","article-title":"Isolation of Moenjodaramine from Buxus papilosa","volume":"1","author":"Atta-ur-Rahman","year":"1983","journal-title":"Planta Med."},{"key":"10.1016\/j.bbrc.2020.01.123_bib101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.steroids.2014.12.002","article-title":"Bioactive steroidal alkaloids from Buxus macowanii Oliv","volume":"95","author":"Lam","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.bbrc.2020.01.123_bib102","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1099-4831(08)00203-4","article-title":"Buxus steroidal alkaloids: chemistry and biology","volume":"66","author":"Ata","year":"2008","journal-title":"Alkaloids - Chem. Biol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib103","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.foodchem.2016.10.029","article-title":"Ursolic acid from apple pomace and traditional plants: a valuable triterpenoid with functional properties","volume":"220","author":"Cargnin","year":"2017","journal-title":"Food Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib104","doi-asserted-by":"crossref","first-page":"E2751","DOI":"10.3390\/molecules24152751","article-title":"Ursolic acid and its derivatives as bioactive agents","volume":"24","author":"Mlala","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2020.01.123_bib105","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s12272-015-0587-6","article-title":"Anti-inflammatory, antioxidant and anti-acetylcholinesterase activities of Bouvardia ternifolia: potential implications in Alzheimer\u2019s disease","volume":"38","author":"Garc\u00eda-Morales","year":"2015","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.bbrc.2020.01.123_bib106","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.1021\/jf501487v","article-title":"Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages","volume":"62","author":"Jang","year":"2014","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib107","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mnfr.200700389","article-title":"Ursolic acid: an anti- and pro-inflammatory triterpenoid","volume":"52","author":"Ikeda","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bbrc.2020.01.123_bib108","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mnfr.200600279","article-title":"Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases","volume":"51","author":"Neto","year":"2007","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bbrc.2020.01.123_bib109","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ptr.5529","article-title":"The hypoglycemic and synergistic effect of loganin, morroniside, and ursolic acid isolated from the fruits of Cornus officinalis","volume":"30","author":"He","year":"2016","journal-title":"Phytother Res."},{"key":"10.1016\/j.bbrc.2020.01.123_bib110","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1021\/acs.jafc.8b06954","article-title":"Ursolic acid isolated from the leaves of loquat (Eriobotrya japonica) inhibited osteoclast differentiation through targeting exportin","volume":"67","author":"Tan","year":"2019","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib111","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11101-014-9349-1","article-title":"Phytochemistry and bioactivity of aromatic and medicinal plants from the genus Agastache (Lamiaceae)","volume":"13","author":"Zieli\u0144ska","year":"2014","journal-title":"Phytochemistry Rev."},{"key":"10.1016\/j.bbrc.2020.01.123_bib112","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bioorg.2018.12.013","article-title":"Ursolic and oleanolic acid derivatives with cholinesterase inhibiting potential","volume":"85","author":"Loesche","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib113","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1021\/jf501314g","article-title":"p-Coumaric acid and ursolic acid from Corni fructus attenuated \u03b2-amyloid(25-35)-induced toxicity through regulation of the NF-\u03baB signaling pathway in PC12 cells","volume":"62","author":"Yoon","year":"2014","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib114","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.3390\/molecules17033524","article-title":"Terpenoids as potential anti-Alzheimer\u2019s disease therapeutics","volume":"17","author":"Yoo","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2020.01.123_bib115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1016-8478(23)17016-6","article-title":"Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase","volume":"11","author":"Chung","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2020.01.123_bib116","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.bmcl.2007.12.016","article-title":"Antimitotic quinoid triterpenes from Maytenus chuchuhuasca","volume":"18","author":"Morita","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bbrc.2020.01.123_bib117","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.chroma.2003.11.072","article-title":"Preparative isolation and purification of celastrol from Celastrus orbiculatus Thunb. by a new counter-current chromatography method with an upright coil planet centrifuge","volume":"1028","author":"Wu","year":"2004","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.bbrc.2020.01.123_bib118","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ps.953","article-title":"Antifungal properties of pristimerin and celastrol isolated from Celastrus hypoleucus","volume":"61","author":"Luo","year":"2005","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.bbrc.2020.01.123_bib119","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.fct.2010.11.044","article-title":"Celastrol isolated from Tripterygium regelii induces apoptosis through both caspase-dependent and independent pathways in human breast cancer cells","volume":"49","author":"Yang","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejphar.2019.03.036","article-title":"Celastrol induce apoptosis of human multiple myeloma cells involving inhibition of proteasome activity","volume":"853","author":"Zhong","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib121","doi-asserted-by":"crossref","first-page":"152805","DOI":"10.1016\/j.phymed.2018.12.028","article-title":"Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1\/2 and p38 MAPK signaling pathway","volume":"58","author":"Hsieh","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2020.01.123_bib122","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2009.09.006","article-title":"Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation","volume":"290","author":"Lu","year":"2010","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2020.01.123_bib123","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/CAD.0b013e328330fd90","article-title":"Triterpenoids as new promising anticancer drugs","volume":"20","author":"Petronelli","year":"2009","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.bbrc.2020.01.123_bib124","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0278-5846(01)00192-0","article-title":"Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer\u2019s disease","volume":"25","author":"Allison","year":"2001","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbrc.2020.01.123_bib125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.homp.2014.08.003","article-title":"Effect of homeopathic Lycopodium clavatum on memory functions and cerebral blood flow in memory-impaired rats","volume":"104","author":"Hanif","year":"2015","journal-title":"Homeopathy"},{"key":"10.1016\/j.bbrc.2020.01.123_bib126","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2003-38489","article-title":"Alpha-onocerin: an acetylcholinesterase inhibitor from Lycopodium clavatum","volume":"69","author":"Orhan","year":"2003","journal-title":"Planta Med."},{"key":"10.1016\/j.bbrc.2020.01.123_bib127","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.mito.2019.01.003","article-title":"Withaferin A-mediated apoptosis in breast cancer cells is associated with alterations in mitochondrial dynamics","volume":"47","author":"Sehrawat","year":"2019","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbrc.2020.01.123_bib128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-016-2303-x","article-title":"Withaferin A and its potential role in glioblastoma (GBM)","volume":"131","author":"Dhami","year":"2017","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib129","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/ijms17030290","article-title":"A\u00a0natural anticancer agent with pleitropic mechanisms of action","volume":"17","author":"Lee","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2020.01.123_bib130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.phymed.2018.09.017","article-title":"Different effects of 4\u03b2-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells","volume":"53","author":"Wang","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2020.01.123_bib131","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1078\/0944-7113-00089","article-title":"Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia","volume":"9","author":"Bhattacharya","year":"2002","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2020.01.123_bib132","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lfs.2003.07.007","article-title":"Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves","volume":"74","author":"Jayaprakasam","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2020.01.123_bib133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phytochem.2014.12.026","article-title":"Carnosic acid","volume":"115","author":"Birti\u0107","year":"2015","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbrc.2020.01.123_bib134","doi-asserted-by":"crossref","first-page":"10576","DOI":"10.1021\/jf102042g","article-title":"Characterization of phenolic composition in Lamiaceae spices by LC-ESI-MS\/MS","volume":"58","author":"Hossain","year":"2010","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2006-957066","article-title":"Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis","volume":"73","author":"Lee","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.bbrc.2020.01.123_bib136","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14786410500462843","article-title":"Constituents of Salvia microphylla","volume":"20","author":"Aydogmu\u015f","year":"2006","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bbrc.2020.01.123_bib137","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2174\/18715273113126660157","article-title":"Molecular interaction of acetylcholinesterase with carnosic acid derivatives: a neuroinformatics study","volume":"13","author":"Merad","year":"2014","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.bbrc.2020.01.123_bib138","doi-asserted-by":"crossref","first-page":"E731","DOI":"10.3390\/nu8110731","article-title":"Carnosic acid enhances the anti-lung cancer effect of cisplatin by inhibiting myeloid-derived suppressor cells","volume":"8","author":"Moore","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2020.01.123_bib139","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1570163814666170413121732","article-title":"Anti-carcinogenic effects of carnosol - an updated review","volume":"15","author":"Samarghandian","year":"2018","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib140","first-page":"2","article-title":"The relationship between root growth and the cryptotanshinone content of Salvia miltiorrhiza","volume":"8","author":"Chen","year":"1983","journal-title":"Zhongyao Tongbao"},{"key":"10.1016\/j.bbrc.2020.01.123_bib141","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1248\/cpb.45.1306","article-title":"Aldose reductase inhibitory constituents of the root of Salvia miltiorhiza Bunge","volume":"45","author":"Tezuka","year":"1997","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.bbrc.2020.01.123_bib142","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1271\/bbb.63.2236","article-title":"Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza Bunge","volume":"63","author":"Lee","year":"1999","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib143","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/138920007780655441","article-title":"Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer\u2019s disease, across the blood-brain barrier","volume":"8","author":"Yu","year":"2007","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib144","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2004-815535","article-title":"Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza","volume":"70","author":"Ren","year":"2004","journal-title":"Planta Med."},{"key":"10.1016\/j.bbrc.2020.01.123_bib145","doi-asserted-by":"crossref","first-page":"104254","DOI":"10.1016\/j.phrs.2019.104254","article-title":"Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge","volume":"145","author":"Chen","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2020.01.123_bib146","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2019.02.017","article-title":"Dihydrotanshinone exhibits an anti-inflammatory effect in\u00a0vitro and in\u00a0vivo through blocking TLR4 dimerization","volume":"142","author":"Yuan","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2020.01.123_bib147","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/13880209.2015.1027408","article-title":"Salvia miltiorrhiza: a source for anti-Alzheimer\u2019s disease drugs","volume":"54","author":"Zhang","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib148","doi-asserted-by":"crossref","first-page":"235","DOI":"10.17305\/bjbms.2017.1800","article-title":"Salvia miltiorrhiza extract dihydrotanshinone induces apoptosis and inhibits proliferation of glioma cells","volume":"17","author":"Cao","year":"2017","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.bbrc.2020.01.123_bib149","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.lfs.2013.07.007","article-title":"Dihydrotanshinone induces p53-independent but ROS-dependent apoptosis in colon cancer cells","volume":"93","author":"Wang","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2020.01.123_bib150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.orggeochem.2017.03.011","article-title":"Identification of di-and triterpenoid lipid tracers confirms the significant role of autoxidation in the degradation of terrestrial vascular plant material in the Canadian Arctic","volume":"108","author":"Rontani","year":"2017","journal-title":"Org. Geochem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib151","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.phytochem.2016.01.015","article-title":"Sesquiterpenoids and tirucallane triterpenoids from the roots of Scorzonera divaricate","volume":"124","author":"Yang","year":"2006","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbrc.2020.01.123_bib152","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/np0004808","article-title":"New peroxy triterpenes from the aerial roots of Ficus microcarpa","volume":"64","author":"Chiamg","year":"2001","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.bbrc.2020.01.123_bib153","first-page":"267","article-title":"Antibacterial triterpenoids from Melia toosendan","volume":"9","author":"Zhu","year":"2015","journal-title":"Record Nat. Prod."},{"key":"10.1016\/j.bbrc.2020.01.123_bib154","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.phytochem.2009.06.020","article-title":"Hydroperoxy-cycloartane triterpenoids from the leaves of Markhamia lutea, a plant ingested by wild chimpanzees","volume":"70","author":"Lacroix","year":"2009","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbrc.2020.01.123_bib155","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/np900835k","article-title":"Limonoids and triterpenoids from the stem bark of Melia toosendan","volume":"73","author":"Zhang","year":"2010","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.bbrc.2020.01.123_bib156","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1016\/S0960-894X(98)00644-1","article-title":"Cytotoxic cycloartane-type triterpenes from Combretum quadrangulare","volume":"8","author":"Banskota","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bbrc.2020.01.123_bib157","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1021\/np990336q","article-title":"Thirteen novel cycloartane-type triterpenes from Combretum quadrangulare","volume":"63","author":"Banskota","year":"2000","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.bbrc.2020.01.123_bib158","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1021\/np0502793","article-title":"Dammarane triterpenes from the hypocotyls and fruits of Ceriops tagal","volume":"68","author":"Pakhathirathien","year":"2005","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.bbrc.2020.01.123_bib159","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.phytochem.2010.02.013","article-title":"Fatty acid derivatives and dammarane triterpenes from the glandular trichome exudates of Ibicella lutea and Proboscidea Louisiana","volume":"71","author":"Asai","year":"2010","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbrc.2020.01.123_bib160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10286020701273833","article-title":"Dammarane triterpenes from Ligustrum lucidum","volume":"10","author":"Xu","year":"2008","journal-title":"J.\u00a0Asian Nat. Prod. Res."},{"key":"10.1016\/j.bbrc.2020.01.123_bib161","first-page":"224","article-title":"The connection of chemical constitution and physiological action","volume":"25","author":"Brown","year":"1868","journal-title":"Trans. Roy. Soc. Edinb."},{"key":"10.1016\/j.bbrc.2020.01.123_bib162","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbrc.2020.01.123_bib163","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3762\/bjoc.12.267","article-title":"Computational methods in drug discovery","volume":"12","author":"Leelananda","year":"2016","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.bbrc.2020.01.123_bib164","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1021\/acs.jctc.8b00230","article-title":"Estimation of drug-target residence times by \u03c4-random acceleration molecular dynamics simulations","volume":"14","author":"Kokh","year":"2018","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.bbrc.2020.01.123_bib165","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1039\/C4NP00068D","article-title":"Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review","volume":"31","author":"Lagunin","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbrc.2020.01.123_bib166","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.steroids.2018.10.006","article-title":"Highly oxygenated isoprenoid lipids derived from fungi and fungal endophytes: origin and biological activities","volume":"140","author":"Savidov","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.bbrc.2020.01.123_bib167","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00253-018-09576-z","article-title":"Oxetane-containing metabolites: origin, structures and biological activities","volume":"103","author":"Vil","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrc.2020.01.123_bib168","article-title":"Computer aided prediction of biological activity spectra for chemical compounds: opportunities and limitations","volume":"1","author":"Filimonov","year":"2018","journal-title":"Biom. Chem. Res. Method."},{"key":"10.1016\/j.bbrc.2020.01.123_bib169","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","article-title":"Prediction of the biological activity spectra of organic compounds using the PASS online web resource","volume":"50","author":"Filimonov","year":"2014","journal-title":"Chem. Heterocycl. Compd."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20302060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20302060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:49:04Z","timestamp":1757764144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20302060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":169,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0006291X20302060"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.123","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural and synthetic drugs used for the treatment of the dementia","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}